Kui Chen
No.1 Jianshe East Rd
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial.
Journal: Journal of the American College of Cardiology
Published: March 03, 2026
Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 03, 2025
Effects of residual inflammatory and cholesterol risks on cardiovascular events with evolocumab in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Journal: Lipids in health and disease
Published: December 26, 2024
Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.
Journal: BMC medicine
Published: April 01, 2024
Effects of diagnostic ultrasound with cRGD-microbubbles on simultaneous detection and treatment of atherosclerotic plaque in ApoE-/- mice.
Journal: Frontiers in cardiovascular medicine
Published: May 17, 2022
Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Journal: Clinical therapeutics
Published: January 27, 2022
Efficacy and Safety of Bivalirudin During Percutaneous Coronary Intervention in Chronic Total Occlusion: A Retrospective Study.
Journal: Clinical therapeutics
Published: January 03, 2021
Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis.
Journal: International journal of cardiology
Published: December 08, 2020
Corrigendum to "LncRNA 1700020I14Rik/miR-297a/CGRP axis suppresses myocardial cell apoptosis in myocardial ischemia-reperfusion injury" [Mol. Immunol. 122 (2020) 54-61].
Journal: Molecular immunology
Published: September 24, 2020
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 28, 2020
Last Updated: 09/26/2026